These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12905487

  • 1. Bisphosphonate resistance in Paget's disease of bone.
    Joshua F, Epstein M, Major G.
    Arthritis Rheum; 2003 Aug; 48(8):2321-3. PubMed ID: 12905487
    [Abstract] [Full Text] [Related]

  • 2. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 10. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA.
    J Bone Miner Res; 1990 May; 5(5):483-91. PubMed ID: 2195845
    [Abstract] [Full Text] [Related]

  • 13. Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
    Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Will RK, Prince RL, Criddle A, Bhagat CI, Stuckey BG, Price RI, Kent GN, Faulkner DL, Geelhoed E, Gan SK, Vasikaran S.
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():79-84. PubMed ID: 10510219
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

  • 15. The effects of intravenous alendronate in Paget's disease of bone.
    O'Doherty DP, McCloskey EV, Vasikaran S, Khan S, Kanis JA.
    J Bone Miner Res; 1995 Jul; 10(7):1094-100. PubMed ID: 7484285
    [Abstract] [Full Text] [Related]

  • 16. [Factors that determine intensity of response to treatment with tiludronate in Paget's disease].
    Morales Piga A, Abraira Santos V, Rey Rey JS, de Abajo Iglesias F.
    Med Clin (Barc); 1998 Feb 28; 110(7):254-8. PubMed ID: 9562949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pamidronate infusions for the treatment of Paget's disease of bone.
    Mazieres B, Ahmed I, Moulinier L, Bon E, Cantagrel A, Laroche M.
    Rev Rhum Engl Ed; 1996 Jan 28; 63(1):36-43. PubMed ID: 9064108
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
    Adami S, Salvagno G, Guarrera G, Montesanti F, Garavelli S, Rosini S, Lo Cascio V.
    Calcif Tissue Int; 1986 Oct 28; 39(4):226-9. PubMed ID: 2947663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.